BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EB-SELECT Single-Target CAR-NK Cells readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of EB-SELECT Single-Target CAR-NK Cells\, fr
 om ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07410494-3251@assetmemo.bio
DTSTAMP:20261121T005923Z
DTSTART;VALUE=DATE:20271228
DTEND;VALUE=DATE:20271229
SUMMARY:EB-SELECT Single-Target CAR-NK Cells: Phase 1/2 readout est. (NCT07
 410494)
DESCRIPTION:EB-SELECT Single-Target CAR-NK Cells\, phase 1/2\, Solid Tumors
 .\nStudy: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK 
 Cell Therapy for Advanced Solid Tumors\nEstimated primary completion: 28 D
 ecember 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/eb-sele
 ct-single-target-car-nk-cells#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07410494
URL:https://assetmemo.bio/drug/eb-select-single-target-car-nk-cells#upcomin
 g-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
